Business Description
Modalis Therapeutics Corp
ISIN : JP3922600006
Share Class Description:
TSE:4883: Ordinary SharesTotal Employee Number:
18Description
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in the pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 10.71 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.38 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 32 | |||||
3-Year EPS without NRI Growth Rate | 22 | |||||
3-Year FCF Growth Rate | 27.5 | |||||
3-Year Book Growth Rate | -31.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.53 | |||||
9-Day RSI | 50.77 | |||||
14-Day RSI | 42.58 | |||||
3-1 Month Momentum % | -35.85 | |||||
6-1 Month Momentum % | -46.03 | |||||
12-1 Month Momentum % | -63.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 25.02 | |||||
Quick Ratio | 25.02 | |||||
Cash Ratio | 24.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -43.5 | |||||
Shareholder Yield % | -42.91 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -23.4 | |||||
ROA % | -21.07 | |||||
ROIC % | -468.98 | |||||
3-Year ROIIC % | -1286.59 | |||||
ROCE % | -22.96 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 1.12 | |||||
Price-to-Tangible-Book | 1.12 | |||||
EV-to-EBIT | -0.33 | |||||
EV-to-EBITDA | -0.33 | |||||
EV-to-FCF | -0.06 | |||||
| Price-to-Net-Current-Asset-Value | 1.14 | |||||
| Price-to-Net-Cash | 1.18 | |||||
Earnings Yield (Greenblatt) % | -305.82 | |||||
FCF Yield % | -64.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Modalis Therapeutics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -8.4 | ||
| Beta | 0.19 | ||
| 3-Year Sharpe Ratio | -0.33 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 71.5 | ||
| 14-Day RSI | 42.58 | ||
| 14-Day ATR (円) | 2.692413 | ||
| 20-Day SMA (円) | 33.05 | ||
| 12-1 Month Momentum % | -63.83 | ||
| 52-Week Range (円) | 30 - 97 | ||
| Shares Outstanding (Mil) | 96.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Modalis Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Modalis Therapeutics Corp Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Modalis Therapeutics Corp Frequently Asked Questions
What is Modalis Therapeutics Corp(TSE:4883)'s stock price today?
The current price of TSE:4883 is 円34.00. The 52 week high of TSE:4883 is 円97.00 and 52 week low is 円30.00.
When is next earnings date of Modalis Therapeutics Corp(TSE:4883)?
The next earnings date of Modalis Therapeutics Corp(TSE:4883) is .
Does Modalis Therapeutics Corp(TSE:4883) pay dividends? If so, how much?
Modalis Therapeutics Corp(TSE:4883) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Modalis Therapeutics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers